United States Court of Appeals for the Second Circuit: Michelet Charles, Carol Small, Plaintiffs-Appellants, v. Orange County, State of New York, Orange County Sheriff's Department, Orange County Department of Mental Health, Nicole Kaye, Clinic Director, Orange County Correctional Facility, in her individual capacity, Carmen Elizondo, Former Clinic Director, Orange County Correctional Facility, in her individual capacity

2018 ◽  
Author(s):  
Ira A. Burnim ◽  
Aaron M. Panner
2006 ◽  
Vol 34 (3) ◽  
pp. 629-631
Author(s):  
Susan Herrick

The Bazelon Center for Mental Health Law (the Center), founded as the Mental Health Law Project by a group of attorneys and mental health professionals, has been a major advocacy force promoting the civil rights of persons with mental disabilities since the 1972 New York Willowbrook litigation.Named for D. C. Circuit Court of Appeals Judge David L. Bazelon, whose opinions first articulated the principles that the mentally disabled have a right to treatment in the least restrictive alternative setting, the Center has actively pursued greater rights for the mentally disabled in housing, education, and federal entitlements such as Medicaid, as well as in treatment-related issues.


2021 ◽  
Author(s):  
Anthony D Mancini ◽  
Gabriele Prati

How does the prevalence of COVID-19 impact people’s mental health? In a preregistered study (N = 857), we sought to answer this question by comparing demographically matched samples in four regions in the United States and Italy with different levels of cumulative COVID-19 prevalence. No main effect of prevalence emerged. Rather, prevalence region had opposite effects, depending on the country. New York City participants (high prevalence) reported more general distress, PTSD symptoms, and COVID-19 worry than San Francisco (low prevalence). Conversely, Campania participants (low prevalence) reported more general distress, PTSD symptoms, and COVID-19 worry than Lombardy (high prevalence). Consistent with these patterns, COVID-19 worry was more strongly linked with general distress and PTSD symptoms in New York than San Francisco, whereas COVID-19 worry was more strongly linked with PTSD in Campania than Lombardy. In exploratory analyses, media exposure predicted and mapped on to geographic variation in mental health outcomes.


Subject Salman v United States. Significance The Supreme Court ruled in Salman v United States on December 6 that inside traders may still be liable for insider trading crimes even when no actual quid pro quo exchange between insiders took place. This ruling rejected an earlier interpretation by the US Court of Appeals in New York, which threatened to make prosecutions for insider trading more difficult. This decision comes as the incoming administration of President-elect Donald Trump pledges to overhaul the financial regulatory efforts of the Obama administration, a politically fraught proposition. Impacts The Trump administration may pursue selective enforcement of financial wrongdoing without accompanying structural reform. The Democrats will seek to build a narrative of a ‘business-as-usual’ Republican government in response to its deregulation push. New York state and local officials’ regulatory clout over the financial sector will give them national and international influence.


2006 ◽  
Vol 34 (4) ◽  
pp. 826-828
Author(s):  
Erika Wilkinson

The United States Court of Appeals for the Second Circuit recently upheld United States District Court for the Eastern District of New York Judge's denial of petitioner's application for a writ of habeas corpus. The Court held that it was not objectively unreasonable for the Appellate Division to conclude, in light of clearly established federal law as expressed by the Supreme Court of the United States, that a New York statute providing for the recommitment of specific defendants who plead not responsible by reason of mental disease or defect (NRRMDD) under a mere “preponderance of the evidence” standard does not violate either due process or the equal protection clause of the Fourteenth Amendment.


2021 ◽  
pp. 43-58
Author(s):  
Edward Shorter

The take-off of psychopharmacology in the mental-hospital world began in the vast asylum system of New York State in the early 1950s. Henry Brill ordered the state system to introduce chlorpromazine in 1955, which led to the first decrease in the census of the state asylum system in peacetime. Sidney Merlis and Herman Denber implemented chlorpromazine in their hospitals and, with Brill, began a series of publications on the drugs and their efficacy. Pharmacologist and psychiatrist Joel Elkes established the first department of experimental psychiatry in the world in 1951 at the University of Birmingham in England. Finally, the chapter examiunes the historical heft of the National Institute of Mental Health, which in 1953 opened the “intramural” (in-house) research program where much of the research in psychopharmacology done in the United States has occurred.


Sign in / Sign up

Export Citation Format

Share Document